for
30
Nov
Transcranial magnetic stimulation design goes deeper into brain
-
By
user
As medical researchers push to develop new treatments for a variety of brain-related disorders, transcranial magnetic stimulation (TMS)...
30
Nov
Lose ‘13lbs in 8wks’ by adding potatoes to meals – but they got to be cooked a certain way
-
By
If you want to lose weight, there's no shortage of advice. But %%post_title% can be an effective weight-loss tool, if used correctly.
...
30
Nov
Major discovery about mammalian brains surprises researchers
-
By
Scientists have discovered that a specific type of brain cell found in humans and other mammals is capable of generating electrical imp...
30
Nov
Higher vitamin K intake linked to lower bone fracture risk late in life
-
By
A higher intake of dietary vitamin K has been linked with a decreased risk of hip and other osteoporotic fractures in elderly women, ac...
29
Nov
Drug triggers immune cells to attack prostate cancer
-
By
Cancer trigger: Drug forces immune cells to attack prostate cancer
A new drug that could help to fight prostate cancer has been develo...
29
Nov
COVID-19: The spike protein is no longer the only target
-
By
The novel coronavirus pandemic has upended life as we know it. With the emergence of COVID-19, the world is faced with a new and deadly...
28
Nov
Lose weight fast this winter by drinking two warm drinks ‘in the afternoon’ – ‘it helps’
-
By
Looking to shed some pounds? You're not alone! According to the CDC, more than one-third of U.S. adults are obese. That number has been...
28
Nov
Study challenges ‘good’ cholesterol’s role in universally predicting heart disease risk
-
By
According to a new study, cholesterol may not be as good of a predictor of heart disease risk as previously thought. The study, which w...
27
Nov
Challenging guidelines on pregnancy interval following miscarriage or abortion
-
By
It is well-known that pregnancy loss can be emotionally devastating. While most women who miscarry go on to have healthy pregnancies, a...
27
Nov
New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies, study finds
-
By
A new study has found that the Omicron subvariant BQ.1.1 is resistant to all therapeutic antibodies. This is a major concern for the me...